Darbepoetin Alfa Injection bulk supplier for pharma manufacturers

Darbepoetin Alfa Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mcg, 20 mcg, 30mcg, 40mcg, 50 mcg and 100 mcg

Reference Brands: Aranesp (US & EU), Cresp (India)

Darbepoetin Alfa Injection is a long-acting ESA used to treat anemia in chronic kidney disease and cancer patients. Marketed as Aranesp® in the US and EU, it is ideal for nephrology and oncology care, and widely used in Pharma B2B supply chains.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Darbepoetin Alfa Injection is a long-acting erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy. Designed to reduce the frequency of dosing compared to epoetin alfa, it supports effective red blood cell production in patients with renal or cancer-related anemia. It is marketed under the brand names Aranesp® in both the US and EU. Ideal for hospital use and nephrology practices, Darbepoetin Alfa is a vital product for pharmaceutical distributors and global buyers. Partner with us for high-quality Darbepoetin Alfa Injection for your B2B pharma supply and international procurement needs.

Darbepoetin Alfa Injection — third party manufacturing & bulk supply

Darbepoetin Alfa Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Darbepoetin Alfa Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Darbepoetin Alfa Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Darbepoetin Alfa Injection →

Back to Listing

Frequently Asked Questions

Darbepoetin Alfa Injection is used to treat anemia caused by chronic kidney disease and anemia in patients receiving chemotherapy. It helps stimulate the production of red blood cells in the body.

Darbepoetin Alfa is a recombinant erythropoiesis-stimulating agent (ESA) produced using biotechnology that stimulates the bone marrow to produce more red blood cells.

Common trade names include Aranesp, Cresp, Nesp, and Dargen.

The original brand Aranesp was developed and marketed by the pharmaceutical company Amgen, while other pharmaceutical companies manufacture biosimilar darbepoetin alfa products.

The generic name is Darbepoetin Alfa.

Common brand names include Aranesp, Cresp, Nesp, and Dargen.

Darbepoetin Alfa Injection is manufactured in several countries including the United States, India, and other regions by different pharmaceutical manufacturers.